indobufen has been researched along with dinoprostone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Somma, M; Ferrario, R; Patrignani, P; Patrono, C; Romanzini, L; Volpi, D | 1 |
| Banfi, C; Barbieri, SS; Brambilla, M; Colli, S; Eligini, S; Saliola, M; Tremoli, E; Violi, F | 1 |
2 other study(ies) available for indobufen and dinoprostone
| Article | Year |
|---|---|
Effects of racemic, S- and R-indobufen on cyclooxygenase and lipoxygenase activities in human whole blood.
Topics: Adult; Arachidonate 5-Lipoxygenase; Calcimycin; Cyclooxygenase Inhibitors; Dinoprostone; Female; Humans; In Vitro Techniques; Isoindoles; Leukotriene B4; Lipoxygenase Inhibitors; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Stereoisomerism; Thromboxane B2 | 1990 |
Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism.
Topics: Cells, Cultured; Cyclooxygenase Inhibitors; Depression, Chemical; Dinoprostone; Flow Cytometry; Humans; Isoindoles; Lipopolysaccharides; Monocytes; Phenylbutyrates; Thromboplastin; Thromboxane A2; Thromboxane B2; Thromboxanes | 2006 |